This handout is for immune thrombocytopenia (chronic, outpatient). Your care team identified this based on: itp persisting >12 months on problem list (ash 2019 neunert; provan 2019 international consensus).
Other reasons your team may use this plan: persistent platelet <100k after first-line failed (ash 2019 neunert).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| eltrombopag | 50 mg PO daily (25 mg if East Asian / hepatic impairment) | PO | daily | RAISE (Cheng Lancet 2011); ASH 2019 Neunert; preferred oral; LFT monitoring; avoid divalent cations within 4 hours |
| romiplostim | 1 mcg/kg SC weekly, titrate to plt 50-200k | SC | weekly | Kuter Lancet 2008; ASH 2019 Neunert; SC route |
| avatrombopag | 20 mg PO daily with food | PO | daily, titrate to 40 mg max | Jurczak Br J Haematol 2018; BSH 2024; no food restrictions vs eltrombopag |
Plan: Chronic ITP maintenance — TPO-RA / rituximab / fostamatinib / splenectomy (ASH 2019 Neunert; BSH 2024; Provan 2019)
Use these zones to know what to do based on how you feel.
Call 911 or go to the nearest emergency room right away if you have:
Vaccinations (encapsulated organisms if splenectomy planned) (ASH 2019 Neunert), pregnancy planning (Provan 2019), dental procedures plan
Guideline: ASH 2019 ITP Guidelines (Neunert, Blood Adv 2019, PMID 31794604) + BSH 2024 + Provan 2019 international consensus report